Viewing Study NCT05937906


Ignite Creation Date: 2025-12-26 @ 2:38 PM
Ignite Modification Date: 2026-01-01 @ 2:30 AM
Study NCT ID: NCT05937906
Status: RECRUITING
Last Update Posted: 2025-10-02
First Post: 2023-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.
Sponsor: Centre Georges Francois Leclerc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module